Studies were performed in isolated, Langendorff-perfused rat hearts and anesthetized dogs
to determine the effects of synthetic atrial natriuretic peptide (ANP 8-33) on the coronary …

The effects of the synthetic 28-amino-acid alpha-human atrial natriuretic peptide (ANP) on
the proximal coronary arteries and coronary blood flow were evaluated in 17 patients …

To examine the mechanism by which atrial natriuretic peptide (ANP) decreases cardiac
output, we studied changes in the heart, peripheral circulation, and blood flow distribution in …

Atriopeptin II has been reported to cause profound coronary vasoconstriction in the isolated
perfused guinea pig heart and in the blood perfused canine heart. Consequently, this study …

Atrial natriuretic peptides (ANP) reduce blood pressure. Animal experiments suggest that
this depressor action results from a reduction in cardiac output rather than peripheral …

The effects of atrial natriuretic peptide (ANP) on proximal epicardial coronary artery
dimensions and coronary blood flow were examined in 7 awake dogs chronically …

The effects of atrial natriuretic peptide (ANP) infusion were determined in 9 subjects
undergoing cardiac catheterization that did not disclose heart disease. Data were obtained …

A trial natriuretic peptide (ANP) is synthesized and stored within atrial myocytes, and
released in response to increased atrial pressure. It possesses vasodilator properties and …

Studies of the effects of atrial natriuretic peptide on the coronary circulation have yielded
conflicting results in animals and have not been fully investigated in human subjects. To …

The natriuretic, diuretic, and hypotensive effects of atrial natriuretic peptide (ANP) were
examined in rats 4 wk after myocardial infarction induced by left coronary artery ligation …